Dr. Khaled El-Shami, MD

Dr. El-Shami practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.

Dr. El-Shami's NPI, 1639225204, was assigned on January 26, 2007. Dr. El-Shami holds Maryland license D65486.

Dr. El-Shami's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.

Dr. El-Shami's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. Dr. El-Shami is also affiliated with MedStar Georgetown University Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. El-Shami to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. El-Shami practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. El-Shami's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. El-Shami is licensed in Maryland.

CMS data shows 1,042 Medicare services from Dr. El-Shami across 5 procedure codes in 2024, for 287 Medicare patients. Medicare paid $113,496 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. El-Shami in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. El-Shami's median patient age at 78, with 47% women.

In 2024, Dr. El-Shami wrote 708 Medicare Part D claims for 121 patients. 67% of them were for generic drugs. CMS names the drug for 422 of them, across 22 drugs with 11 or more claims each, at $2,226,078 in total drug cost. In 2023, CMS named 218 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. El-Shami for performance year 2024, reported as part of a group. CMS lists Dr. El-Shami as offering telehealth.

Dmand AI links 2 papers to Dr. El-Shami, published from 2015 to 2022.

CMS Open Payments shows 113 general payments to Dr. El-Shami from 8 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 78% of the total. Bristol-Myers Squibb Company paid the most, $123,345.